Peijun Cao

Tianjin, 300052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker  for Lung Adenocarcinoma

Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker  for Lung Adenocarcinoma

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: January 31, 2024

Pan-cancer analysis combined with experiments predicts NNMT as a therapeutic target for human cancers.

Pan-cancer analysis combined with experiments predicts NNMT as a therapeutic target for human cancers.

Journal: Discover oncology

Published: November 11, 2023

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.

Journal: Journal of Cancer

Published: November 06, 2023

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.

Journal: Frontiers in immunology

Published: September 29, 2023

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population.

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population.

Journal: OncoTargets and therapy

Published: May 04, 2023

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer.

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer.

Journal: Frontiers in oncology

Published: May 04, 2023

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

Journal: Cell death & disease

Published: April 10, 2023

Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy.

Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy.

Journal: Frontiers in pharmacology

Published: January 09, 2023

LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma.

LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma.

Journal: Frontiers in immunology

Published: November 12, 2022

Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma.

Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma.

Journal: Frontiers in immunology

Published: July 14, 2022

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis.

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis.

Journal: Frontiers in genetics

Published: June 16, 2022

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.

Journal: Frontiers in oncology

Published: January 08, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026